These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26545986)

  • 1. Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST).
    Scutt P; Blackburn D; Krishnan K; Ballard C; Burns A; Ford GA; Mant J; Passmore P; Pocock S; Reckless J; Sprigg N; Stewart R; Wardlaw JM; Bath PM
    Trials; 2015 Nov; 16():509. PubMed ID: 26545986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids.
    Blackburn DJ; Krishnan K; Fox L; Ballard C; Burns A; Ford GA; Mant J; Passmore P; Pocock S; Reckless J; Sprigg N; Stewart R; Wardlaw J; Bath PM
    Trials; 2013 Nov; 14():401. PubMed ID: 24266960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.
    Bath PM; Scutt P; Blackburn DJ; Ankolekar S; Krishnan K; Ballard C; Burns A; Mant J; Passmore P; Pocock S; Reckless J; Sprigg N; Stewart R; Wardlaw JM; Ford GA;
    PLoS One; 2017; 12(1):e0164608. PubMed ID: 28095412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.
    Zanchetti A; Liu L; Mancia G; Parati G; Grassi G; Stramba-Badiale M; Silani V; Bilo G; Corrao G; Zambon A; Scotti L; Zhang X; Wang H; Zhang Y; Zhang X; Guan TR; Berge E; Redon J; Narkiewicz K; Dominiczak A; Nilsson P; Viigimaa M; Laurent S; Agabiti-Rosei E; Wu Z; Zhu D; Rodicio JL; Ruilope LM; Martell-Claros N; Pinto F; Schmieder RE; Burnier M; Banach M; Cifkova R; Farsang C; Konradi A; Lazareva I; Sirenko Y; Dorobantu M; Postadzhiyan A; Accetto R; Jelakovic B; Lovic D; Manolis AJ; Stylianou P; Erdine S; Dicker D; Wei G; Xu C; Xie H; Coca A; O'Brien J; Ford G
    J Hypertens; 2014 Sep; 32(9):1888-97. PubMed ID: 24979303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an INTEnsive blood pressure Reduction in Acute Cerebral hemorrhage Trial (INTERACT2): protocol and baseline characteristics of patients included in France].
    Delcourt C; Stapf C; Tzourio C; Héritier S; Anderson C
    Rev Neurol (Paris); 2012 Apr; 168(4):321-7. PubMed ID: 22129475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
    Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
    Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.
    Anderson CS; Huang Y; Wang JG; Arima H; Neal B; Peng B; Heeley E; Skulina C; Parsons MW; Kim JS; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Heritier S; Morgenstern LB; Chalmers J;
    Lancet Neurol; 2008 May; 7(5):391-9. PubMed ID: 18396107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
    Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
    Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
    Saposnik G; Goodman SG; Leiter LA; Yan RT; Fitchett DH; Bayer NH; Casanova A; Langer A; Yan AT; ; ;
    Stroke; 2009 Apr; 40(4):1417-24. PubMed ID: 19213947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.
    Peters R; Beckett N; Nunes M; Fletcher A; Forette F; Bulpitt C
    Drugs Aging; 2006; 23(1):83-92. PubMed ID: 16492072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care.
    Fletcher K; Mant J; McManus R; Campbell S; Betts J; Taylor C; Virdee S; Jowett S; Martin U; Greenfield S; Ford G; Freemantle N; Hobbs FD
    BMC Cardiovasc Disord; 2010 Aug; 10():37. PubMed ID: 20696047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nurse-led, telephone-based secondary preventive follow-up benefits stroke/TIA patients with low education: a randomized controlled trial sub-study.
    Irewall AL; Ögren J; Bergström L; Laurell K; Söderström L; Mooe T
    Trials; 2019 Jan; 20(1):52. PubMed ID: 30646948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acupuncture and computer-assisted cognitive training for post-stroke attention deficits: study protocol for a randomized controlled trial.
    Huang J; McCaskey MA; Yang S; Ye H; Tao J; Jiang C; Schuster-Amft C; Balzer C; Ettlin T; Schupp W; Kulke H; Chen L
    Trials; 2015 Dec; 16():546. PubMed ID: 26631161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phone-based Intervention under Nurse Guidance after Stroke (PINGS): study protocol for a randomized controlled trial.
    Sarfo FS; Treiber F; Jenkins C; Patel S; Gebregziabher M; Singh A; Sarfo-Kantanka O; Saulson R; Appiah L; Oparebea E; Ovbiagele B
    Trials; 2016 Sep; 17(1):436. PubMed ID: 27596244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
    Pearce LA; McClure LA; Anderson DC; Jacova C; Sharma M; Hart RG; Benavente OR;
    Lancet Neurol; 2014 Dec; 13(12):1177-85. PubMed ID: 25453457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Martyr A; Lloyd-Williams H; Brand A; Gutting P; Hoare Z; Edwards RT; Clare L
    Trials; 2016 Mar; 17():152. PubMed ID: 27000036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nurse-Led, Telephone-Based, Secondary Preventive Follow-Up after Stroke or Transient Ischemic Attack Improves Blood Pressure and LDL Cholesterol: Results from the First 12 Months of the Randomized, Controlled NAILED Stroke Risk Factor Trial.
    Irewall AL; Ögren J; Bergström L; Laurell K; Söderström L; Mooe T
    PLoS One; 2015; 10(10):e0139997. PubMed ID: 26474055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can cardiovascular risk management be improved by shared care with general practice to prevent cognitive decline following stroke/TIA? A feasibility randomised controlled trial (SERVED memory).
    Davison WJ; Myint PK; Loke YK; Ravenhill G; Turner D; Fox C; Shepstone L; Potter JF
    BMC Geriatr; 2020 Sep; 20(1):353. PubMed ID: 32943015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.